ea0046p21 | (1) | UKINETS2016
Kordatou Zoe
, Papaxoinis George
, McCallum Lynn
, Salih Zena
, Nasralla Magdy
, Nonaka Daisuke
, Mansoor Wasat
Background: Pulmonary carcinoids (PC) are rare neuroendocrine tumors (NETs). The course of PCs is considered to be indolent, but patients with advanced disease have low survival rates and their treatment options are limited. As PCs are under-represented in trials, therapeutic decisions are based on evidence extrapolated from other types of NETS. Capecitabine-Temozolamide (CAPTEM) has demonstrated significant efficacy in pancreatic NETs. However, its role in PCs is still unexpl...